Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage

Junwei Yang, Yixuan Zhang, Jing Xu et al. · 2009

Read Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage by Junwei Yang, Yixuan Zhang, Jing Xu et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004181.txt.

Description

Junwei Yang and colleagues published this infection study in PLOS ONE in 2009. Bleeding in the lungs is a major and often deadly feature of severe leptospirosis. Leptospirosis is a bacterial infection caught from animal-contaminated water, and the cause of its lung bleeding is unclear. The dangerous serovar Lai of Leptospira interrogans makes a protein that acts on platelet-activating factor, a blood signal.

Following that clue, the team measured the activity of the matching enzyme, PAF acetylhydrolase, in patients' blood. They propose its serum activity as a possible clinical marker for the lung bleeding form of the disease. An early warning marker could help doctors spot the patients most at risk.

Catalog record

CREATORJunwei Yang, Yixuan Zhang, Jing Xu et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004181

Browse the full library · About the Tower of Babel